Home » Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor
Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor
The FDA will complete its review and provide an action letter to Somaxon
Pharmaceuticals relating to the Silenor NDA by December 4.
Seeking Alpha
Seeking Alpha
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May